These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23532910)

  • 21. Expression of the hepatocyte growth factor and c-Met in colon cancer: correlation with clinicopathological features and overall survival.
    Liu Y; Li Q; Zhu L
    Tumori; 2012; 98(1):105-12. PubMed ID: 22495710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of HGF and its receptor c-Met in renal cell carcinoma].
    Shi BB; Zhang XH; Wang HJ; Li HZ
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):356-8. PubMed ID: 15312347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
    Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
    Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-Met expression in gastric cancer with liver metastasis.
    Amemiya H; Kono K; Itakura J; Tang RF; Takahashi A; An FQ; Kamei S; Iizuka H; Fujii H; Matsumoto Y
    Oncology; 2002; 63(3):286-96. PubMed ID: 12381909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
    Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H
    Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
    Solano-Iturri JD; Beitia M; Errarte P; Calvete-Candenas J; Etxezarraga MC; Loizate A; Echevarria E; Badiola I; Larrinaga G
    Aging (Albany NY); 2020 May; 12(11):10337-10358. PubMed ID: 32428869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
    Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
    Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells.
    Firtina Karagonlar Z; Koc D; Iscan E; Erdal E; Atabey N
    Cancer Sci; 2016 Apr; 107(4):407-16. PubMed ID: 26790028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
    Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations.
    Galimi F; Torti D; Sassi F; Isella C; Corà D; Gastaldi S; Ribero D; Muratore A; Massucco P; Siatis D; Paraluppi G; Gonella F; Maione F; Pisacane A; David E; Torchio B; Risio M; Salizzoni M; Capussotti L; Perera T; Medico E; Di Renzo MF; Comoglio PM; Trusolino L; Bertotti A
    Clin Cancer Res; 2011 May; 17(10):3146-56. PubMed ID: 21447729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer.
    Osada S; Matsui S; Komori S; Yamada J; Sanada Y; Ihawa A; Tanaka Y; Tokuyama Y; Okumura N; Nonaka K; Hosono Y; Takahashi T; Yamaguchi K; Yoshida K
    Hepatogastroenterology; 2010; 57(97):76-80. PubMed ID: 20422876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases.
    Maurer CA; Graber HU; Friess H; Beyermann B; Willi D; Netzer P; Zimmermann A; Büchler MW
    Surgery; 1999 Nov; 126(5):869-80. PubMed ID: 10568187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells.
    Herynk MH; Zhang J; Parikh NU; Gallick GE
    J Exp Ther Oncol; 2007; 6(3):205-17. PubMed ID: 17552361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases.
    Al-Mulla F; Keith WN; Pickford IR; Going JJ; Birnie GD
    Genes Chromosomes Cancer; 1999 Apr; 24(4):306-14. PubMed ID: 10092128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer.
    Zhang KL; Zhu WW; Wang SH; Gao C; Pan JJ; Du ZG; Lu L; Jia HL; Dong QZ; Chen JH; Lu M; Qin LX
    Theranostics; 2021; 11(13):6560-6572. PubMed ID: 33995676
    [No Abstract]   [Full Text] [Related]  

  • 36. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-met overexpression in supraglottic laryngeal squamous cell carcinoma and its relation to lymph node metastases.
    Yücel OT; Sungur A; Kaya S
    Otolaryngol Head Neck Surg; 2004 Jun; 130(6):698-703. PubMed ID: 15195055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.
    Miranda E; Bianchi P; Destro A; Morenghi E; Malesci A; Santoro A; Laghi L; Roncalli M
    Cancer; 2013 Jan; 119(2):266-76. PubMed ID: 22786759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
    Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
    Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
    Sarris M; Lee CS
    Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.